Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from NVO

4 Medical Stocks That Could Help the Health of Investors’ Portfolios

The healthcare sector often fares well during difficult times due to the constant need for its goods and services. Therefore, quality medical stocks Novo Nordisk (NVO), AmerisourceBergen (ABC), Cardinal Health (CAH), and Haemonetics (HAE) might be the best investments for investors’ portfolios given current macroeconomic headwinds. Read on….

StockNews.com

3 No-Brainer Stocks to Buy Right Now

Amid the banking turmoil and the Fed’s latest quarter-point rate hike, the odds of a recession are back on the rise. Hence, it could be wise to invest in no-brainer stocks Taiwan Semiconductor Manufacturing (TSM), Novo Nordisk (NVO), and Merck & Co. (MRK) now. Read more….

StockNews.com

3 Stocks Every Investor Should Own

The Fed’s commitment to tame the sticky inflation is feared to trigger an economic slowdown in the near term. Amid such concerns, investors’ anxiety has been rising. Against this backdrop, quality stocks Novo Nordisk (NVO), Altria Group (MO), and Cardinal Health (CAH) might be owned by every trader at least…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 High-Quality Stocks to Buy Now and Hold for the Next Decade

With the Fed extremely likely to raise the benchmark interest rates higher than envisaged by policymakers, the economy and the stock market are expected to remain under pressure. Amid the uncertainty, it could be wise to invest in high-quality stocks Visa (V), Novo Nordisk A/S (NVO), and Autodesk (ADSK) for…

StockNews.com

AI Stock Headlines 5 Leaders Flashing Buy Signals As Market Rally Gains Steam

Arista Networks, which keeps popping up on lists of top AI stocks, leads this weekend's watch list of 5 stocks near buy points.

Investors Business Daily

CBS '60 Minutes' Story Turns FDA Headlights On Diabetes and Weight Loss Drug Stock

Growth stock Novo Nordisk is showing strength after FDA approval of breakthrough oral drug for type 2 diabetes. Shares are in a base.

Investors Business Daily

1 Pharma Stock That Could Help You Become a Millionaire

Prominent pharma player Novo Nordisk (NVO) posted solid revenue and earnings growth in fiscal 2022. The company’s long-term growth is expected to be spearheaded by its immensely popular GLP-1 drug Wegovy. Given the potential of its current portfolio of drugs and drugs under research, investing in this stock could be…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 High-Quality Stocks to Pick up in 2023

With slowing inflation, resilient economic growth, and a robust labor market aided by a slower rate hike by the Fed, fundamentally strong stocks Exxon Mobil (XOM), Novo Nordisk (NVO), and Bridgestone (BRDCY) seem to be good investments now. Continue reading….

StockNews.com

Prime-Time Battles Drive GSK And Novo Nordisk In 2023; Novartis Preps Its Spinoff

GSK stock and NVO stock rose Wednesday, though both beat forecasts. Novartis stock skidded on lighter-than-expected sales.

Investors Business Daily

Best Stocks to Buy Right Now? 3 Large Caps to Watch this Week

Although inflation has cooled down over the past few months, the Fed intends to keep raising interest rates until inflation falls to its desired level. This is expected to push the economy into a recession. Investors looking to stabilize their portfolios against potential market volatility might look to add large-cap…

StockNews.com

How Novo Nordisk Just Expanded Its Diabetes Lead Over Pfizer, Eli Lilly

The Food and Drug Administration expanded the label for Novo Nordisk's oral diabetes medicine, leading NVO stock to jump Friday.

Investors Business Daily

3 High-Flying Pharma Stocks to Buy Right Now

The healthcare industry is poised to grow significantly in the coming years. Moreover, as healthcare stocks tend to perform relatively well despite macro uncertainties due to inelastic demand for their products and services, high-flying pharma stocks Novo Nordisk (NVO), AbbVie (ABBV), and Merck & Co (MRK) might be ideal investments…

StockNews.com

How Novo Nordisk Is Trying To Lengthen Its Lead In Weight Loss Over Eli Lilly

Novo Nordisk is planning to boost production for weight-loss shot Wegovy as Eli Lilly angles for approval. NVO stock surged Wednesday.

Investors Business Daily

5 “Strong Buy” Health Care Stocks to Buy This Week

Rising prevalence of chronic diseases and the increasing aging population are significant growth drivers of the healthcare industry. Moreover, growing investments in technological advancements should bode well for the industry. Thus, we think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer (PFE), Novo Nordisk (NVO), Bristol-Myers Squibb (BMY),…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Stocks to Buy That Won’t Give You Any Headaches

The stock market has witnessed significant volatility amid the record high inflation and the Fed’s hawkish stance on it. Investors have been banking on healthcare stocks as they tend to hold up relatively well in such turbulent times. We think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer…

StockNews.com

5 “Strong Buy” Stocks to Buy This Week

The Fed’s hawkish stance on inflation, along with other macroeconomic issues, has created substantial market volatility. However, it might be better to stay invested to reap long-term returns. To that end, fundamentally sound stocks Novo Nordisk (NVO), Centene (CNC), McKesson (MCK), Universal Logistics (ULH), and Sisecam Resources (SIRE) might be…

Investors Business Daily

Novo Nordisk's Obesity Sales Nearly Doubled, But That Wasn't Enough For NVO Stock

Danish drugmaker Novo Nordisk missed quarterly views Wednesday, but raised its full-year outlook. Still, NVO stock tumbled.

StockNews.com

3 Stocks No One Is Talking About but Should Be

Amid an uncertain market, it becomes increasingly difficult for investors to find stocks that can survive the challenges and deliver solid returns. Accel Entertainment (ACEL), Novo Nordisk (NVO), and Titan Machinery (TITN) are currently not on investors’ radar, but it could be worth adding these stocks to one’s portfolio given…

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Coal Stocks Today: Why Alliance Resource Partners Remains A Stock Market Leader

Fund ownership has been increasing at Alliance Resource in at least the past three quarters.

Benzinga

Here's How Much $1000 Invested In Novo Nordisk 5 Years Ago Would Be Worth Today

Novo Nordisk (NYSE:NVO) has outperformed the market over the past 5 years by 12.09% on an annualized basis producing an average annual return of 21.31%. Currently, Novo Nordisk has a market capitalization of $251.98 billion.

StockNews.com

5 "Strong Buy" Pharmaceutical Stocks to Own for the Long Haul

The inelastic demand and rising investments in research and development should drive the pharmaceutical industry’s growth in the long run. Therefore, pharmaceutical stocks AbbVie (ABBV), Amgen (AMGN), Catalyst (CPRX), Novo Nordisk (NVO), and Vertex (VRTX), which possess sound fundamentals, could be solid long-term investments. These stocks are rated Strong Buy…

Benzinga

If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today

Novo Nordisk (NYSE:NVO) has outperformed the market over the past 10 years by 3.35% on an annualized basis producing an average annual return of 14.11%. Currently, Novo Nordisk has a market capitalization of $238.19 billion.

Investors Business Daily

We're Looking At Obesity In A New Way — And 4 Pharmaceutical Stocks Could Benefit

A group of pharmaceutical stocks are climbing as they pivot their diabetes drugs to help treat obesity. A potential multibillion-dollar market beckons them.

StockNews.com

3 High-Quality Large-Cap Stocks to Buy This Month

The better-than-expected May employment report indicates that the Federal Reserve will continue to raise interest rates aggressively this year. Since the fears of an economic slowdown are expected to keep the stock market extremely volatile, it could be wise to bet on high-quality large-cap stocks McKesson (MCK), Novo Nordisk (NVO),…

Zenger

VIDEO: War In Ukraine: Russian Troops Fire Mortar Rounds At Ukrainian Targets

This is the moment Russian troops fire mortar rounds at Ukrainian targets.

1 2

People

Dipanjan BanchurSince

397 stories

Kritika SarmahHer

266 stories

Sristi Suman Jayaswal

90 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.